戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ulfilling stringent morphologic criteria for myxoma.
2 h imaging characteristics most suggestive of myxoma.
3 naesthesia and reported to be a conjunctival myxoma.
4 ed: either an aortic dissection or an atrial myxoma.
5 m metastases associated with the left atrial myxoma.
6     One of the most common cardiac tumors is myxoma.
7 ng to the standard morphologic definition of myxoma.
8 ncluding one with isolated inherited cardiac myxomas.
9 artial resection in benign tumors other than myxomas.
10 ith conjunctival myxoid lesions diagnosed as myxoma (16/28), conjunctival stromal tumor (10/28), or r
11 nd in 2 lesions with morphologic features of myxoma (2/14, 14%), 1 of which demonstrated a pathogenic
12  tissue after surgery of primary sarcoma, 2; myxoma, 4; fibroelastoma, 1; caseous calcification of mi
13  identified: 106 rhabdomyoma, 25 fibroma, 14 myxoma, 6 vascular, 4 teratoma, 3 lipoma, and 15 other.
14 milar to fat surrounding these intramuscular myxomas (71% at MR imaging) corresponded histologically
15 istent with previous reports on conjunctival myxoma:80-84, 1986).
16 on of primary cardiac tumors; 163 (50%) with myxomas, 83 (26%) with papillary fibroelastomas, 18 (6%)
17                    This case of conjunctival myxoma adds to the small number of documented cases, by
18  report an 11-year- old boy with left atrial myxoma and multiple cerebral oncotic aneurysms.
19 ve than combination therapy using unmodified myxoma and systemic alphaPD1 antibodies.
20 art-hand syndrome involving familial cardiac myxomas and distal arthrogryposis and demonstrate that t
21  distinguish between neoplastic conjunctival myxomas and other myxoid lesions, underscoring the impor
22 istic features such as cardiac and cutaneous myxomas and spotty pigmentation of the skin.
23         A large family with familial cardiac myxomas and the trismus-pseudocamptodactyly syndrome (Fa
24 acilitate diagnosis and treatment of cardiac myxomas and will foster new concepts in regulation of ca
25 th cutaneous hyperpigmentation, extracardiac myxomas, and nonmyxomatous tumors.
26                            Syndromic cardiac myxomas are associated with spotty pigmentation of the s
27                                      Cardiac myxomas are benign mesenchymal tumors that can present a
28 on adult cardiac tumor, and familial cardiac myxomas are now appreciated to be caused by mutations in
29                                 Intracardiac myxomas are significant causes of cardiovascular morbidi
30                                              Myxomas are the most common adult cardiac tumor, and fam
31 minant syndrome Carney complex, intracardiac myxomas arise in the setting of lentiginosis and other l
32 drome Carney complex, which includes cardiac myxomas as one of its cardinal features.
33  exhibited cytogenetic aberrations in atrial myxomas associated with the complex, and has been charac
34 racterized by multiple neoplasias, including myxomas at various sites and endocrine tumors, and lenti
35 myxoma, thus early diagnosis of conjunctival myxoma can prevent potentially devastating consequences
36                                 Conjunctival myxomas can occur in association with the Carney Complex
37 ith a PRKAR1alpha deletion revealed that the myxoma cells retain both the wild-type and the mutant PR
38                         Resection of cardiac myxomas, chemotherapy, radiotherapy, coil embolization a
39 nter study of all patients with conjunctival myxoma, conjunctival stromal tumor, or reactive fibromyx
40                      Reviews of conjunctival myxoma, corneal pyogenic granuloma, and limbal juvenile
41                             Skin and cardiac myxomas, Cushing syndrome, and acromegaly were present i
42  spotty skin pigmentation, cardiac and other myxomas, endocrine tumours and psammomatous melanotic sc
43 ents who underwent resection of fibromas and myxomas had superior survival characteristics in compari
44 nt long-term survival; patients with cardiac myxomas have survival characteristics that are not signi
45 al lesions; and its association with cardiac myxoma, highlights the need for cardiac investigations i
46 s of 45 pathologically confirmed soft-tissue myxomas in 44 patients were retrospectively reviewed.
47  the study period, we identified 112 cardiac myxomas in the pathology database and 142 in the echocar
48 me characterized by cardiac and extracardiac myxomas in the setting of spotty skin pigmentation and e
49 cluding lentigines, blue nevi, and cutaneous myxomas in unusual locations such as oral and genital mu
50  plays a role in determining the outcomes of myxoma infection and that this effect could be physiolog
51 how that even at an early stage (6 and 12 h) myxoma infection causes profound changes in cancer cell
52 erebral (oncotic) aneurysms following atrial myxoma is a rare neurological complication.
53 n all patients who present with conjunctival myxoma (J Ophthalmol (1);1-5, 2014; Ophthalmic Surg Lase
54            These biochemical changes lead to myxoma-like changes, indicating that these mice may be a
55 ic investigations of primary cardiac tumors (myxomas, lipomas, rhabdomyomas, and fibromas) have provi
56                                  Soft-tissue myxoma more commonly affected women (59%; average age 52
57 = 12), hemangioma (n = 9), thrombus (n = 4), myxoma (n = 3), teratoma (n = 2), and paraganglioma, per
58 ardium, and were diagnosed pathologically as myxomas (n = 2) or thrombi (n = 5), or they resolved wit
59 skin, suggest that familial lentiginosis and myxomas occur in skin areas specifically enriched in der
60                             Familial cardiac myxomas occur in the hereditary syndrome Carney complex.
61                                  Soft-tissue myxoma often demonstrates characteristic US, CT, and MR
62          Although we did not observe cardiac myxomas or altered pigmentation in prkar1a(+/-) mice, we
63 bility (OR, 2.90; CI, 1.56-5.39; P < 0.001), myxoma (OR, 2.43; CI, 1.39-4.26; P = 0.002), diabetes me
64  the development of a subset of conjunctival myxomas, particularly in tumors fulfilling stringent mor
65 ead to new species, as has occurred with the myxoma poxvirus in rabbits.
66 x, ectromelia, gerbilpox, herpes, monkeypox, myxoma, rabbitpox, raccoonpox, skunkpox, vaccinia, and v
67                  The cumulative incidence of myxoma recurrence was 13% and occurred in a younger popu
68 ation, DNA and protein analyses of an atrial myxoma resected from a Carney complex patient with a PRK
69 2002 U.S. population, patients who underwent myxoma resection had survival characteristics that were
70 erferon and interferon-induced genes such as myxoma resistance gene 1 (Mx1) and retinoic acid-inducin
71  MYH8 polymorphisms in patients with cardiac myxoma syndromes but without arthrogryposis.
72 histotypes (93.2%) were benign (rhabdomyoma, myxoma, teratoma, fibroma, and hemangioma).
73 vascular embolic events secondary to cardiac myxoma, thus early diagnosis of conjunctival myxoma can
74 c glioma model in immunocompetent mice after Myxoma virus (MYXV) administration.
75 irus evolution.IMPORTANCE The coevolution of myxoma virus (MYXV) and European rabbits in Australia is
76                                              Myxoma virus (MYXV) and vaccinia virus (VACV), two disti
77                           The coevolution of myxoma virus (MYXV) and wild European rabbits in Austral
78                                          The myxoma virus (MYXV) carries three tandem C7L-like host r
79              IMPORTANCE The evolution of the myxoma virus (MYXV) following its release as a biologica
80 be determined.IMPORTANCE The species jump of myxoma virus (MYXV) from the South American tapeti to th
81                                              Myxoma virus (MYXV) has been evolving in a novel host sp
82 cumented field example is the coevolution of myxoma virus (MYXV) in European rabbits.
83                                              Myxoma virus (MYXV) is a poxvirus pathogenic only for Eu
84                                              Myxoma virus (MYXV) is a rabbit-specific poxvirus that e
85                                              Myxoma virus (MYXV) is a rabbit-specific poxvirus, which
86                          The M141 protein of myxoma virus (MYXV) is a viral CD200 homolog (also calle
87 w that the replication of the model poxvirus myxoma virus (MYXV) is delayed by elevated levels of ext
88                                              Myxoma virus (MYXV) M062R is a functional homolog of the
89 ft model, we serendipitously discovered that myxoma virus (MYXV) prevented GVHD while permitting GVM.
90 e antiviral granules in the cytoplasm during myxoma virus (MYXV) replication in human cancer cells.
91              We studied a modified oncolytic myxoma virus (MYXV) that shows high efficiency for tumor
92                                              Myxoma virus (MYXV), a Leporipoxvirus, is being develope
93 e replication stage in human cancer cells of myxoma virus (MYXV), a member of the double-stranded DNA
94                The rabbit-specific poxvirus, myxoma virus (MYXV), encodes four unique ANK repeat prot
95 iruses, the distantly related leporipoxvirus myxoma virus (MYXV), which infects RIPK3-deficient hosts
96                                          The myxoma virus (MYXV)-encoded pyrin domain-containing prot
97                                 Here we test myxoma virus (MYXV)-infected tumor-specific T (T(MYXV))
98 inhibition, we generated a novel recombinant myxoma virus (vPD1), which inhibits the PD1/PDL1 pathway
99                                  Poxviruses, myxoma virus and vaccinia virus specifically, utilize a
100                         Serp-1 is a secreted myxoma virus anti-inflammatory serine proteinase inhibit
101     To characterize the ongoing evolution of myxoma virus in Australian rabbits, we used experimental
102 ock the productive replication and spread of myxoma virus in human fibroblasts.
103 -MS based metabolomics, we characterized the myxoma virus infection induced metabolic changes in thre
104 es in cancer cells associated with oncolytic myxoma virus infection.
105                                              Myxoma virus is a rabbit poxvirus that belongs to the Le
106  Serp2 protein encoded by the leporipoxvirus myxoma virus is essential for full virulence and, like c
107                                              Myxoma virus is nonpathogenic in mice, whereas systemic
108  to those coding for interleukin-1 receptor, myxoma virus M003.2 and M004.1 genes (two copies each),
109 romelia virus macrophage host range protein, myxoma virus M011L, variola virus B22R, four ankyrin rep
110                    M156R, the product of the myxoma virus M156R open reading frame, has sequence simi
111  determined the crystal structures of C7 and myxoma virus M64, a C7 family member that is unable to a
112 ermediate transcription factor gene with the myxoma virus ortholog.
113                    This slows the release of myxoma virus particles from the endosomes, resulting in
114 structure of M156R, the first structure of a myxoma virus protein.
115 ntagonized in a dose-dependent manner by the myxoma virus rabbit IFN-gamma receptor homolog, M-T7.
116 lular K(+) concentrations required to impact myxoma virus replication can be reached in viral lesions
117 some poxvirus serpins regulate inflammation (myxoma virus SERP1 and cowpox virus [CPV] crmA/SPI-2) or
118 cowpox virus [CPV] crmA/SPI-2) or apoptosis (myxoma virus SERP2 and CPV crmA/SPI-2), the function of
119                             In the 1950s the myxoma virus was released into European rabbit populatio
120 t that infection of primary murine pDCs with myxoma virus, but not with vaccinia virus, induces IFN-a
121 oire of immunoregulatory proteins encoded by myxoma virus, M013 is a viral homologue of the viral pyr
122 that vaccinia virus p28 and its homologue in myxoma virus, M143R, can mediate the formation of polyub
123 in the orthologous M029 protein expressed by myxoma virus, plays an inhibitory role in poxvirus sensi
124 from genetic knockout mice, we show that the myxoma virus-induced innate immune response requires the
125 rmacological inhibitors, we demonstrate that myxoma virus-induced type I IFN and IL-12p70 production
126 , vaccinia virus (VACV), but also cowpox and myxoma viruses, are able to evade host IFN responses.
127      Among these candidates are vaccinia and myxoma viruses, which belong to the family Poxviridae an
128                      However, in this atrial myxoma, we did observe a reversal of the ratio of R1alph

 
Page Top